GLP-1 Pharmacogenomics: The 23andMe Variants That Predict Tirzepatide Side Effects
TL;DR April 2026 Nature paper from 23andMe Research Institute identifies two missense variants — GLP1R rs10305420 (p.Pro7Leu) and GIPR rs1800437 (p.Glu354Gln) — that predict tirzepatide side effects with 14.8x odds ratio for vomiting in double homozygotes. Primary mechanism: Pro7Leu shifts glp-1 receptor signaling bias toward beta-arrestin recruitment (nausea pathway) vs. cAMP (therapeutic pathway); GIPR variant […]
Tesamorelin (Egrifta): The 44-Amino-Acid GHRH That Strips Visceral Fat And Sharpens The Brain
TL;DR What it is: Tesamorelin (brand name Egrifta) — a 44-amino-acid GHRH analog that stimulates the body’s own growth hormone release in natural pulses, not a flat wave. Primary mechanism: Binds GHRH receptors in the pituitary, triggering pulsatile GH secretion → 80% average IGF-1 rise, preserves feedback loops. Who it’s for: Anyone with visceral fat […]
GLP-1 Muscle Loss Concerns: What Tony Huge’s Community Needs to Know
The bodybuilding and biohacking communities have been closely monitoring the rise of glp-1 receptor agonists like Ozempic and Wegovy, particularly concerning their potential impact on muscle mass. Recent findings suggesting that GLP-1 use may not lead to as much muscle loss as some experts feared represent a significant development for those in Tony Huge’s sphere […]
Myostatin Blockers + GLP-1: Game-Changer for Muscle Preservation
A groundbreaking development in the intersection of weight loss and muscle preservation has emerged from recent clinical research, revealing how myostatin inhibition could revolutionize the way bodybuilders and fitness enthusiasts approach glp-1 peptide therapy. This breakthrough addresses one of the most significant concerns in Tony Huge’s community: maintaining hard-earned muscle mass during cutting phases and […]
SARM Liver Toxicity: What Bodybuilders Must Know
A groundbreaking study published in Cureus has sent shockwaves through the bodybuilding and performance enhancement community, revealing previously underestimated liver toxicity risks associated with Selective Androgen Receptor Modulators (SARMs). This research comes at a crucial time when sarms usage has exploded among athletes and fitness enthusiasts seeking alternatives to traditional anabolic steroids. The findings underscore […]
FDA Approves P-15 Peptide for Bone Growth: Biohacker Insights
The peptide research landscape has reached a significant milestone with the FDA’s recent approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft for lumbar fusion procedures. This groundbreaking development marks the first FDA-approved bone growth accelerator utilizing peptide technology, opening new conversations within the biohacking and performance optimization community about peptide applications in recovery and regenerative […]
GLP-1 Combo Therapy: Fat Loss Without Muscle Loss Breakthrough
A groundbreaking clinical trial has demonstrated that combination glp-1 therapy can effectively reduce body fat while preserving lean muscle mass—a development that could revolutionize body recomposition strategies for bodybuilders, fitness enthusiasts, and biohackers worldwide. The research, recently published in Medical Xpress, represents a significant advancement in addressing one of the most persistent challenges in physique […]
C-Peptide in Clinical Trials: Tony Huge’s Take on Diabetes Research
The peptide research landscape continues to evolve at breakneck speed, with recent developments from Breakthrough T1D highlighting C-peptide as a crucial endpoint in clinical trials. For followers of tony huge and the broader biohacking community, this advancement represents more than just diabetes research—it signals a broader acceptance of peptide-based biomarkers in clinical medicine that could […]
Is MK-677 Natty? The Honest Researcher’s Answer (2026)
MK-677 is not natty — it elevates GH and IGF-1 above natural baselines, fails every WADA/NPC Natural drug test, and shows up as institutional cheating in tested sport. Here’s the science.
RFK Jr. Peptide Ban Reversal: What It Means for Biohackers
The biohacking and performance optimization community received unexpected news when reports emerged that Robert F. Kennedy Jr. has proposed reversing the ban on 14 specific peptides. This development has sparked intense discussion among researchers, biohackers, and advocates for health freedom—including those who follow Tony Huge’s research into cutting-edge performance enhancement compounds. According to SELF Magazine, […]